News
03-11-2016, 10:15 AM
Researchers have shown for the first time that it is possible to use a multi-gene test to identify patients with early breast cancer who can be spared chemotherapy and who will still be alive and well five years after diagnosis.
More... (http://www.news-medical.net/news/20160311/Multi-gene-test-can-help-identify-early-breast-cancer-patients-who-can-safely-be-spared-chemotherapy.aspx)
More... (http://www.news-medical.net/news/20160311/Multi-gene-test-can-help-identify-early-breast-cancer-patients-who-can-safely-be-spared-chemotherapy.aspx)